Stockscreener 앱 받기
94.39
0.43%
0.40
Astrazeneca PLC 주식(AZN)의 최신 뉴스
Trend Review: Does AstraZeneca PLC Depositary Receipt have a sustainable dividendEarnings Miss & Weekly High Momentum Picks - baoquankhu1.vn
AstraZeneca share price steadies after Thursday drop as traders eye Nasdaq-100 reshuffle - TechStock²
AstraZeneca’s Cell Therapy Manufacturing Facility, Maryland, USA - Pharmaceutical Technology
AstraZeneca (AZN) Weighs FDA Fast-Track Risks Amid Legal Concerns - GuruFocus
AstraZeneca (AZN) Acquires Modella AI to Boost Cancer Research - GuruFocus
AstraZeneca Acquires Modella AI to Accelerate Cancer Therapy Development - Intellectia AI
JPMorgan Chase & Co. Reiterates Overweight Rating for AstraZeneca (LON:AZN) - MarketBeat
AstraZeneca (AZN) Involvement in Emergent's Legal Settlement - GuruFocus
What Makes AstraZeneca (AZN) a Strong Growing Company? - Insider Monkey
AstraZeneca Spotlights 2025 Growth, 2026 Launch Wave and $80B 2030 Goal at JPM Conference - Yahoo Finance
The Newest Stock in the Nasdaq-100 Soared 549,000% Since Its IPO, and It's Still a Buy Right Now, According to Wall Street (Hint: Not Strictly a Tech Company) - The Motley Fool
Rep. Julia Letlow Buys AstraZeneca PLC (NASDAQ:AZN) Shares - MarketBeat
AstraZeneca (NASDAQ:AZN) Stock Acquired Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
JPM26: AstraZeneca bids to accelerate oncology R&D with Modella AI acquisition - Pharmaceutical Technology
Manning & Napier Advisors LLC Sells 390,342 Shares of AstraZeneca PLC $AZN - MarketBeat
Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global Scale - marketscreener.com
AstraZeneca (LON:AZN) Hits New 52-Week HighHere's Why - MarketBeat
Market Overview: Whats AstraZeneca PLC Depositary Receipts historical returnMarket Performance Recap & Intraday High Probability Alerts - baoquankhu1.vn
AstraZeneca: acquires Modella AI to strengthen its oncology research - marketscreener.com
AstraZeneca stock rating reiterated at Buy by Guggenheim ahead of Q4 results - Investing.com UK
AstraZeneca CFO on M&A Strategy and Obesity Market - marketscreener.com
AstraZeneca to acquire Modella AI to speed oncology drug research - Reuters
AstraZeneca (AZN) Awaits Conclusion of US Pharma Import Probe - GuruFocus
Illumina Announces Alliance Framework with AstraZeneca, Merck, and Eli Lilly and Company - marketscreener.com
AstraZeneca (AZN) Broadens Oncology Efforts with Acquisition of ModellaAI - GuruFocus
AstraZeneca acquires AI firm to boost research - breakingthenews.net
Risks Report: What technical charts say about AstraZeneca PLC Depositary Receipt stockJuly 2025 Fed Impact & Weekly Return Optimization Plans - Bộ Nội Vụ
Modella AI announces acquisition by AstraZeneca - marketscreener.com
AstraZeneca (AZN) Joins in Groundbreaking Genetic Research Initiative - GuruFocus
AstraZeneca (AZN) Progresses with Phase 3 TROPION-Lung17 Trial - GuruFocus
Walmart to join Nasdaq 100 on Jan. 20 as AstraZeneca exits - MSN
AstraZeneca (AZN) Set for Removal from Several Key Nasdaq Indexes - GuruFocus
SG Americas Securities LLC Grows Stock Position in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca to be replaced by Walmart in the Nasdaq-100 index — Check dates - The Financial Express
J.P. Morgan Maintains ASTRAZENECA PLC(AZNCF.US) With Buy Rating, Cuts Target Price to $215.25 - 富途牛牛
Oliver Luxxe Assets LLC Buys 13,350 Shares of AstraZeneca PLC $AZN - MarketBeat
The Truth About AstraZeneca plc: Wall Street Sleeper Stock Or Overhyped Dinosaur? - AD HOC NEWS
The Truth About AstraZeneca plc: Is This Pharma Giant Still Worth Your Money? - AD HOC NEWS
Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) – Here’s Why - Insider Monkey
AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next - TechStock²
Walmart to join Nasdaq 100 from January 20 as AstraZeneca exits the index - MSN
The Truth About AstraZeneca plc: Why Everyone Is Suddenly Watching This Pharma Giant - AD HOC NEWS
Walmart to Join Nasdaq 100 Index on January 20 as AstraZeneca Exits - scanx.trade
AstraZeneca: Oncology Dominance Justifies New All-Time Highs (NASDAQ:AZN) - Seeking Alpha
Walmart Set to Enter Nasdaq 100 on January 20, Replacing AstraZeneca - Bitget
HB Wealth Management LLC Has $3.65 Million Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC (NASDAQ:AZN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
AstraZeneca - Britannica
Walmart joins Nasdaq 100 on January 20, replacing AstraZeneca - MSN
Walmart joins Nasdaq 100, $19 billion investment surge coming - Cryptopolitan
Walmart set to join Nasdaq 100 on January 20 as AstraZeneca drops out - Business Standard
Walmart to join Nasdaq 100 on Jan 20 as AstraZeneca exits - The Edge Malaysia
Walmart To Join Nasdaq 100 on Jan. 20 as AstraZeneca Exits - Bloomberg
Walmart to replace Astrazeneca on Nasdaq-100 on Jan 20 - marketscreener.com
Walmart to replace Astrazeneca on Nasdaq-100 - marketscreener.com
Oak Family Advisors LLC Sells 23,242 Shares of AstraZeneca PLC $AZN - MarketBeat
AZN Stock Price, Forecast & Analysis | ASTRAZENECA PLC-SPONS ADR (NASDAQ:AZN) - Chartmill
Can AstraZeneca PLC (ZEG) stock sustain institutional flowsJuly 2025 Chart Watch & Fast Entry High Yield Tips - ulpravda.ru
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Can AstraZeneca PLC (Common Stock) (ZEGA) stock sustain breakout momentumRisk Management & Real-Time Stock Price Movement Reports - ulpravda.ru
Pharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Benzinga
자본화:
|
볼륨(24시간):